Identifying FLT3 Mutations in AML

Virtual Event:

Identifying FLT3 Mutations in Acute Myeloid Leukemia (AML) to Inform Clinical Decision-making – A Focus on Relapsed/Refractory Disease

No continuing education (CE) or continuing medical education (CME) credit can be provided for this presentation sponsored by Astellas Pharma US, Inc.

PRESENTER
Catherine Lai, M.D., M.P.H.
Medstar Georgetown University Hospital ; Lombardi Comprehensive Cancer Center ; Georgetown University Medical Center
Washington, DC

*Important note: Attendees are required to view the presented slides during the virtual program

To RSVP for this program – Please contact:

Melba Vasquez
melba.vasquez@astellas.com

Or go to: https://astellas.virtualspeakercast.net/Registration/index/236

Kindly reply by March 23, 2021

In the RSVP, please include your name, contact information, organization, and specialty.
Date/Time
Date(s) - 03/30/21
3:30 pm - 4:00 pm
Contact/Email
Melba Vasquez

About us

The Silicon Valley chapter of the Oncology Nursing Society is committed to provide mechanisms to further the professional development of the individual members within the chapter.

A secondary but equally important mission is to provide an atmosphere of collegial, professional and emotional support to the chapter membership throughout the continued transition in health care as it exists in the state of California and as it evolves throughout the nation..

Contact Info

a 503c Organization, Santa Clara, CA, USA